MDT delivers strong earnings in the fiscal 2025 third quarter, with significant improvements in both gross and operating margins.
Tuesday, Medtronic Plc MDT reported third-quarter 2025 sales of $8.29 billion, missing the consensus of $8.32 billion.
Medtronic (MDT) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.30 per share a year ago.
Medtronic said it is “starting to see the results” of its investment in new products.
Medtronic beat Wall Street estimates for quarterly profit on Tuesday, on strong demand for its heart and diabetes devices.
Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release
In the closing of the recent trading day, Medtronic (MDT) stood at $92.20, denoting a +0.93% change from the preceding trading day.
Beyond analysts' top -and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended January 2025.
Buying battle-tested dividend aristocrats can be a winning strategy for those seeking durable retirement income. What's even better is if they also carry strong balance sheets and are attractively valued. In this article, I highlight 2 such picks, which, on a combined basis, offer immediate diversification and potential for market-beating total returns.
Medtronic expects its fiscal 2025 third-quarter revenues to reflect an unfavorable impact of 1% from currency translation.
In the closing of the recent trading day, Medtronic (MDT) stood at $91.69, denoting a +0.79% change from the preceding trading day.
In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.